Skip to main content
. 2017 Sep 21;9(10):128. doi: 10.3390/cancers9100128

Table 1.

Inhibition of biotinylated fibronectin binding to αVβ6 integrin compared with inhibition of biotinylated vitronectin binding to αVβ3.

Compound αVβ6 IC50 [nM] 1 αVβ3 IC50 [nM] 2 IC50Vβ6)/IC50Vβ3)
1a
c[RGDf(N-Me)V]
82.8 ± 4.9 0.71 ± 0.06 117
1b
c[RGDfV]
104.7 ± 18.9 3.2 ± 1.3 33
1c
c[RGDfK]
52.0 ± 23.8 1.4 ± 0.2 37
2 345.0 ± 1.0 3.2 ± 2.7 108
3 95.6 ± 24.6 4.5 ± 1.1 21
4 95.3 ± 4.9 7.6 ± 4.3 13
5 173.5 ± 52.5 12.6 ± 5.0 14
6 76.6 ± 4.2 2.1 ± 0.6 37
7 2.3 ± 0.8 0.2 ± 0.09 12
8
c[DKP-3-RAD]
4095 ± 1425 1500 ± 540 3

1 IC50 values were calculated as the concentration of compound required for 50% inhibition of biotinylated fibronectin binding as estimated by GraphPad Prism software; all values are the arithmetic mean ± SD of triplicate determinations. 2 Calculated as the concentration of compound required for 50% inhibition of biotinylated vitronectin binding [24].